Keson Technology announced that in December 2025, the company planned to sell 100% of the shares of Corson Healthcare, a wholly-owned subsidiary, to Yaolingke, with a transaction amount of 915 million yuan. In 2025, we have received an equity transfer of RMB 455,221,420.20, which is a difference of RMB 2,278,579.80 from the first installment. The counterparty will make up for it in January 2026, and the remaining price will be paid within 15 working days of completing the industrial and commercial changes. Currently, the relevant delivery procedures are still being processed, and all deliveries cannot be completed before December 31, 2025. The transaction is expected to increase the company's investment income by about 600 million yuan in 2026. After the transaction is completed, the company will no longer hold shares in Corson Healthcare.

Keson Technology announced that in December 2025, the company planned to sell 100% of the shares of Corson Healthcare, a wholly-owned subsidiary, to Yaolingke, with a transaction amount of 915 million yuan. In 2025, we have received an equity transfer of RMB 455,221,420.20, which is a difference of RMB 2,278,579.80 from the first installment. The counterparty will make up for it in January 2026, and the remaining price will be paid within 15 working days of completing the industrial and commercial changes. Currently, the relevant delivery procedures are still being processed, and all deliveries cannot be completed before December 31, 2025. The transaction is expected to increase the company's investment income by about 600 million yuan in 2026. After the transaction is completed, the company will no longer hold shares in Corson Healthcare.